We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Partnerships Using Optical Imaging to Fight Cancer

By MedImaging staff writers
Posted on 04 Apr 2007
Experts believe the hospitals could save money and reduce waiting times if optical coherence tomography (OCT) imaging was used instead of taking a biopsy. More...


As a result, two leading UK hospitals have teamed up with Michelson Diagnostics, Ltd. (MDL; Kent) in the fight against cancer. Gloucestershire Royal Hospital and University College London Hospital (UCLH) are both eager to evaluate MDL's latest medical imaging system for research into rapid in-vivo identification of cancers affecting the cervix, esophagus, skin, lung, and other organs.

The new Michelson Diagnostics scanner employs optical coherence tomography (OCT) to visualize tissue structure in real time below the surface of a scanned organ. OCT makes this possible at far higher resolution than is possible with ultrasound or magnetic resonance imaging (MRI) scans.

At Gloucestershire Royal Hospital, Dr. Nick Stone, consultant clinical scientist in biophotonics research, will use the scanner to look at cervical and esophageal tumor tissue. "My team want to assess how useful OCT imaging could be in helping clinicians to diagnose, monitor, and target the treatment of cancer,” said Dr Stone. "The next step will be to repeat the tests in-vivo. We believe the NHS [National Health Service] could reduce costs and waiting times with the clinical implementation of OCT, both for biopsy targeting and real-time diagnostics.”

Dr. Colin Hopper, head of maxillofacial surgery at UCLH, is eager to obtain in-vivo images of basal-cell skin carcinomas with the Michelson Diagnostics system. "We are very excited about the breakthrough in image quality that this system offers,” Dr. Hopper said. "OCT could revolutionize the surveillance of pre-cancers in the mouth by eliminating waiting for biopsy results and by minimizing surgery for cancer through improved disease mapping, all while maximizing cure rates.”

The research programs are due to start in late March 2007. They will last at least four months and will compare OCT scans taken with the Michelson Diagnostics equipment with histology from the same tissue samples from a sizeable range of patients.


Related Links:
Michelson Diagnostics

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.